the combined titer of spiruchostatins a and B, respectively. rt-Pcr analysis indicates that overexpression of heterologous depR upregulates the expression of native spiR.
Introduction
spiruchostatins a and B were discovered as gene expression-enhancing agents and selective inhibitors of class I histone deacetylases (HDacs), while screening for activators of transforming growth factor-β (tGF-β) mediated signaling [14] . spiruchostatins belong to a small family of natural products, which also includes FK228 (Fr901228, romidepsin, marketed as Istodax) [18] [19] [20] , Fr901375 [1, 13] and thailandepsins [22] [23] [24] ; all those compounds are produced by Gram-negative bacteria. structurally spiruchostatins resemble FK228 in having a bicyclic depsipeptide scaffold and a signature disulfide linkage critical for prodrug stability and for bioactivities when reduced (Fig. 1) . close examination of the structure of spiruchostatins a and B reveals a likely sequence of building block polymerization starting with a derivative of l-cysteine, followed by two malonyl coa units, a d-alanine unit, a d-cysteine unit, a derivative of l-valine (in spiruchostatin a) or l-isoleucine (in spiruchostatin B) unit, and finally another malonyl coa unit. Biosynthesis of spiruchostatins in Pseudomonas sp. Q71576 is thus predicted to be catalyzed by a hybrid nonribosomal peptide synthetase (NrPs)-polyketide synthase (PKs) pathway similar to that of FK228 [3, 15, 26] .
as exemplified by FDa approval of FK228 for the treatment of cutaneous t-cell lymphoma and peripheral t-cell lymphoma [4, 21] , other members of this FK228-family Abstract spiruchostatins a and B are members of the FK228-family of natural products with potent histone deacetylase inhibitory activities and antineoplastic activities. However, their production in the wild-type strain of Pseudomonas sp. Q71576 is low. to improve the yield, the spiruchostatin biosynthetic gene cluster (spi) was first identified by rapid genome sequencing and characterized by genetic mutations. this spi gene cluster encodes a hybrid biosynthetic pathway similar to that encoded by the FK228 biosynthetic gene cluster (dep) in Chromobacterium violaceum No. 968. Each gene cluster contains a pathway regulatory gene (spiR vs. depR), but these two genes encode transcriptional activators of different classes. Overexpression of native spiR or heterologous depR in the wild-type strain of Pseudomonas sp. Q71576 resulted in 268 or 1,285 % increase of of natural products have also drawn much attention due to their potent inhibitory activities of human HDacs and antineoplastic activities. For example, spiruchostatin a or B, either as a single agent or in combination with other drugs, has shown promising in vitro and/or in vivo efficacy in colon tumor xenograft model [17] , leukemia cells [10] , idiopathic pulmonary fibroblasts [6] , endometrial carcinoma xenograft model [28] , and renal cell carcinoma xenograft model [27] .
However, efforts to develop a promising natural product drug lead for clinical uses are often hampered by inadequate supply of material, and various approaches have been described for yield improvement, including classical strain mutagenesis, metabolic engineering, and fermentation optimization [2] . spiruchostatins have the same supply issue, and the aim of this study was thus to improve the biosynthetic yield of spiruchostatins. to this end, we first identified and confirmed a gene cluster responsible for the biosynthesis of spiruchostatins in Pseudomonas sp. Q71576; we then individually overexpressed a native transcriptional activator and a heterologous transcriptional activator in two engineered bacterial strains. In both cases, the combined titer of spiruchostatins a and B in bacterial fermentation broth increased significantly. 
Materials and methods

Bacterial
Gene deletion and complementation
Gene deletion in PsWt and gene complementation in mutant strains of PsWt were performed generally according to our established protocols described previously [25] . In particular, a 907-bp DNa fragment containing the spiR OrF and its native ribosome-binding site was amplified by Pcr, digested with XbaI/HindIII, and cloned into the same sites of a broad host-range expression vector pBMtl-3 to make the gene expression construct pBMtl3-spiR; the sequence fidelity of DNa insert was verified by resequencing. Gene expression construct pBMtl3-depR (pVP01-52b) was made and described previously [15] . pBMtl3-depR and pBMtl3-spiR were electroporated independently into Pseudomonas sp. strains with a Gene Pulser (Bio-rad laboratories, Hercules, ca). cells were recovered into 1 ml of sOB, incubated at 30 °c for 1 h and then plated onto selection plates containing 160 µg/ml of Fig. 1 
Fermentation and quantification
Fermentation of Pseudomonas sp. strains was carried out in triplicate in 50 ml of sOB containing 0.5 % (w/v) of HP-20 resin (sigma-aldrich) and 0.5 % (w/v) of XaD16 resin (sigma-aldrich) in 250-ml flasks at 25 °c with shaking at 200 rpm. Overnight grown seed culture was typically inoculated at a 1 % (v/v) ratio. In addition, 160 µg/ ml of chloramphenicol and 1 mM of IPtG were added to the fermentation culture of engineered strains harboring a pBMtl-3 based expression construct. after 7 days, culture was centrifuged at 4,000×g for 30 min and the resulting pellet (resin and cell debris) was lyophilized to dryness. Dried pellet was eluted with 5 ml of ethyl acetate with agitation for 1 h at 30 °c. One milliliter of the extract was centrifuged at 17,000×g for 5 min, and 20 µl of the supernatant was injected into a liquid chromatography-mass spectrometer (lc-MsD trap from agilent technologies, santa clara, ca) for the identification and quantification of spiruchostatins, similarly as the identification and quantification of FK228 described elsewhere [26] .
reverse transcriptase (rt)-Pcr
For strains subjected to rt-Pcr analysis, total rNa was extracted from a 12-h post-induction culture using an rNeasy Mini Kit (Qiagen, Valencia, ca). to remove DNa contamination, rNa samples were digested with DNase I for 1 h at 37 °c; the reactions were then stopped by adding EDta to a final concentration of 0.5 mM and were denatured at 75 °c for 10 min. One hundred nanograms of rNa from each sample were added to each rt-Pcr reaction performed with Qiagen Onestep rt-Pcr kit. cDNa 
Results
Draft genome sequencing of Pseudomonas sp. Q71576 (PsWt)
shotgun sequencing of PsWt genome generated a total of 189,375,961 input bases, which were assembled into 165 contigs; among them 84 are large contigs with an average contig size of 77,009 bps. those contigs were further aligned into 32 scaffolds with a total length of 6,486,271 bps. this draft bacterial genome was thus calculated to have 29.1-fold of sequence coverage, which is close to the desired 30-fold oversampling of raw sequence for the 454 pyrosequencing and de novo assembly technology platform [7] . since the genome sizes of most Pseudomonas species fall between 6 to 7 Mb according to the GenBank data, this 6.48-Mb draft genome sequence of PsWt appears to be near complete. the quality of this draft genome sequence was further assessed by phylogenetic comparison of its full-length 16s rrNa gene sequence to those of 28 Pseudomonas strains and several outgroup bacterial strains, revealing a close taxonomical relatedness of this PsWt to Pseudomonas sp. uK4 and to P. fluorescens sBW25 (Fig. s1 in Electronic supplementary Material).
Identification and confirmation of the spiruchostatin biosynthetic gene cluster a Blastx search of the draft genome sequence of PsWt using our previously published protein sequences of the FK228 biosynthetic (dep) gene cluster (GenBank accession no. EF210776) [3] identified two scaffolds that carry a gene cluster containing genes homologous to most of the dep-genes. three sequence gaps existing within a scaffold or between two scaffolds were closed by Pcr amplification and sequencing, resulting in a 54,335-bp continuous DNa sequence that contains the target gene cluster designated spi for spiruchostatins ( Fig. 2a; table 2 ). the boundaries of this spi gene cluster were determined by gene deletions (Fig. s2 in Electronic supplementary Material) in conjunction with quantification of spiruchostatin titers in fermentation broth ( Fig. 3a; table 3 ; Fig. s3 in Electronic supplementary Material). the upstream boundary of spi gene cluster was determined to start with spiR because deletion of orf−1, a putative gene upstream of spiR, had a negligible effect on the combined titer of spiruchostatins a and B, but deletion of spiR resulted in a 67 % reduction of spiruchostatin titer. Deletion of a key biosynthetic gene, spiA, completely abolished the spiruchostatin production. the downstream boundary of spi gene cluster was determined to end with spiP because deletion of spiP reduced the spiruchostatin titer by more than 80 %, while deletion of orf+1, a putative gene downstream of spiP, did not affect the combined titer of spiruchostatins. although the observed relative abundance of spiruchostatins a/B varied somewhat in some of the mutants, we tended to believe that it was due to the variations of substrate assimilation by the spiruchostatin biosynthetic pathway.
collectively, the spi gene cluster was defined to contain 14 genes ( Fig. 2a; table 2 ), among them, spiA, spiDE1 and spiE2 are NrPs genes, spiB, spiC1 and spiC2 are PKs genes, spiF, spiH and spiJ are genes encoding tailoring proteins, and spiG and spiI are putative resistance genes. spiR encodes an lysr-type transcriptional activator which appears to be dedicated to the biosynthesis spiruchostatins. spiP encodes a putative malonyl coa acyltransferase which may be dedicated to the biosynthesis spiruchostatins.
the genes and their deduced proteins of this spi gene cluster exhibit a significant overall similarity to those of the dep gene cluster ( Fig. 2a; table 2 ). In particular, the deduced products of eight genes (spiA, spiB, spiC1, spiF, spiG, spiH, spiI, and spiJ) share 57 %/74 % or higher sequence identity/similarity with their respective counterparts from the FK228 biosynthetic pathway. the dep gene cluster does not contain a gene encoding the necessary phosphopantetheinyl transferase activity for posttranslational modification of carrier proteins [11]; instead, a discrete sfp gene, physically detached from the dep gene cluster, encodes an sfp-type phosphopantetheinyl transferase for the biosynthesis of FK228 [26] . similarly, the spi gene cluster does not contain a phosphopantetheinyl transferase-encoding gene either; a search of the draft genome of PsWt identified a discrete candidate pcpS gene that encodes a sole Pseudomonas-type carrier protein synthetase (PcPs) [8] which may provide the missing phosphopantetheinyl transferase activity for the biosynthesis of spiruchostatins. additional differences between the two parallel gene clusters or biosynthetic pathways were identified as follows: (1) unlike the FK228 biosynthetic pathway which employs a discrete acyltransferase encoded by either one of the two functionally overlapping housekeeping genes fabD1 and fabD2 located separately from the dep gene cluster [26] , spiP appears to encode the acyltransferase activity necessary for in trans complementing the three "at-less" PKs modules on spiB, spic1 and spic2 proteins; (2) SpiP Fig. 2 Biosynthesis of spiruchostatins. a a comparative map of the spiruchostatin biosynthetic (spi) gene cluster and the FK228 biosynthetic (dep) gene cluster. Genes are color-coded in dark red for nonribosomal peptide synthetase genes, in orange for polyketide synthase genes, in yellow for genes of tailoring enzymes, in blue for resistance genes, and in green for regulatory genes. (N) in gray indicates a pseudogene depN previously defined [15] . a solid line connects two genes whose deduced products have a significant sequence homology and a similar functionality; a dotted line connects two genes whose deduced products may function similarly but do not share a sequence homology. b a proposed model for the biosynthesis of spiruchostatins a and B by a hybrid nonribosomal peptide synthetase-polyketide synthase pathway in Pseudomonas sp. Q71576
downstream of the dep gene cluster and encodes an Oxyrtype transcriptional activator [15] , spiR is located upstream of the spi gene cluster and encodes an lysr-type transcriptional activator; these two deduced regulatory proteins only share weak sequence homology (25 % identity/44 % similarity); (3) there is no depM-equivalent in the spi gene cluster; (4) there are two copies of depC-like gene in the spi gene cluster, the second copy is fused to DNa encoding a likely inactive epimerase (E) domain and is located after spiDE1; (5) a depE-like gene in the spi gene cluster is split into two parts, the first part is fused to the end of spiD, and the second part is transposed to a downstream location between spiG and spiH; (6) unlike the pseudogene "depN", the deduced protein of spiN appears to be a functional peptidyl carrier protein (PcP) containing a critical serine residue for phosphopantetheinylation, but the role of this PcP is yet to be defined. using the proposed FK228 biosynthetic pathway as a reference [3, 15, 26] , we dissected the domain and module organization of six deduced NrPs-and PKs-type enzymes (spia, spiB, spic1, spiDE1, spic2 and spiE2) encoded by the spi gene cluster and proposed a hybrid NrPs-PKs biosynthetic pathway model which also includes three accessory enzymes (spiP, spiF and spiH) (Fig. 2b) . this proposed pathway contains eight biosynthetic modules responsible for seven consecutive steps of building block polymerization that results in a full-length linear intermediate installed to a peptidyl carrier protein domain on the last module. a lactamization process catalyzed by the terminal thioesterase domain is predicted to release the linear intermediate and to form a macrolactam intermediate. Finally, an FaD-dependent oxidoreductase (spiH) is predicted to catalyze a disulfide bond formation as the final step of the biosynthesis of spiruchostatins. PsWt produced c.a. 14.5 mg/l of combined spiruchostatins a and B in the fermentation broth under our laboratory conditions. Overexpression of spiR in PsWt resulted in a 268 % increase of the spiruchostatin production to a combined titer of 53.5 mg/l. Overexpression of depR from the FK228 biosynthetic gene cluster in PsWt resulted in a surprisingly 1,285 % increase of the spiruchostatin production to a combined titer of 200.8 mg/l (Fig. 3b) . to probe the molecular mechanism for this unexpected dramatic boost of spiruchostatin production, the same two overexpression constructs were also introduced into the spiR deletion mutant of Pseudomonas sp. (PsΔspiR). complementation of PsΔspiR with spiR could restore 50 % production capacity of spiruchostatins, whereas depR alone failed to complement the loss of spiR in PsΔspiR.
Furthermore, semi-quantitative rt-Pcr analysis of the expression of depR, spiR, spiA and spiP in PsWt, PsWt/ vector control, PsWt/depR and PsΔspiR/depR showed that overexpression of depR in PsWt directly or indirectly upregulated the expression of spiR, spiA and spiP (Fig. 4) ; however, in the absence of spiR in PsΔspiR, overexpression of depR could not boost the expression of spiA or spiP. It was therefore deduced that the heterologous transcriptional activator Depr exerts its regulatory function through upregulating spiR expression to subsequently enhance the expression of other spi-genes.
Discussion
spiruchostatins structurally resemble FK228 for having a bicyclic peptide scaffold, which bears a signature disulfide linkage critical for prodrug stability as well as for bioactivities when reduced. spiruchostatins differ from FK228 for having three different building blocks (Fig. 1) . those overall structural similarity and yet minor differences are reflected well by the resemblance of the spi and dep biosynthetic gene clusters (Fig. 2a) and their deduced parallel biosynthetic pathways ( Fig. 2b ; see the deduced FK228 biosynthetic pathway in [3] ). Table 3 Quantitative spiruchostatin titers for strains used in Fig. 3 spiruchostatin titer was determined by measuring peak area corresponding to spiruchostatin a and spiruchostatin B and then using a standard curve to generate approximate titer in mg/l. results are the average value of triplicate experiments with standard deviation (sD). spiruchostatins are produced by PsWt at a low titer of 14.5 mg/l, which hampered the development of spiruchostatins toward clinical applications. Possible reasons for the low yield include suboptimal level of gene expression or limited availability of biosynthetic precursors. taking advantage of the biosynthetic gene cluster sequence obtained in this work, modulating the expression of the pathway regulatory gene spiR was first attempted and succeeded. Overexpression of spiR in PsWt resulted in a 268 % increase of the spiruchostatin production to a combined titer of 53.5 mg/l, even without a comprehensive optimization of the fermentation conditions. the biggest surprise came from the overexpression in PsWt of a heterologous regulatory gene depR from the FK228 biosynthetic gene cluster, which resulted in a lofty 1,285 % increase of the spiruchostatin production to a combined titer of 200.8 mg/l. this work demonstrated that the metabolic potential of natural product biosynthetic pathways could be exploited by overexpression of a native or heterologous transcriptional activator.
the deduced product of depR has a significant homology (87 % identity/93 % similarity) to Oxyr protein of Escherichia coli, a pleiotropic regulator known to regulate a variety of cellular processes including oxidative stress response [5] . as determined by rt-Pcr, overexpression of depR in PsWt increased the levels of expression of spiR and other spi-genes (Fig. 4) , suggesting an artificial regulatory cascade where Depr activates the spi gene cluster through spiR. thus, a plausible postulation for the Deprinduced dramatic increase in spiruchostatin titers may have been the binding of Depr to the regulatory elements of spiR which enhanced the spiR expression; elevated spir subsequently acts on other spi-genes to gear up the overall spiruchostatin biosynthetic machinery. additional evidence supporting this postulation came from the observation that, in the absence of spiR, overexpression of depR failed to boost the production of spiruchostatins (Fig. 4) . Fig. 4 rt-Pcr analysis of the effect of depR overexpression on the transcription of spiR, spiA and spiP genes that represent the spi gene cluster. 16s rrNa gene amplification was included in lane 1 of all panels as a positive control. Elevated transcript levels of spiR, spiA and spiP were seen in PsWt/depR whereas spiA or spiP transcript was not detected in PsΔspiR/depR in conditions where they were expressed in PsWt at 12 h of growth
